cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.

cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles (cRGD-HNs) were designed and developed for targeted chemotherapy of human glioma xenografts in mice. As expected, cRGD-HNs had excellent colloidal stability. The in vitro release studies showed that drug release from DOX-loaded cRGD-HNs (cRGD-HN-DOX) was minimal under physiological conditions but markedly accelerated upon NIR irradiation at a low power density of 0.2 W/cm2, due to photothermally induced phase transition of PCL regime. MTT assays showed that the antitumor activity of cRGD-HN-DOX in αvβ3 integrin over-expressed human glioblastoma U87MG cells was greatly boosted by mild NIR irradiation, which was significantly more potent than non-targeting HN-DOX counterpart under otherwise the same conditions and was comparable or superior to free DOX, supporting receptor-mediated endocytosis mechanism. The in vivo pharmacokinetics studies showed that cRGD-HN-DOX had much longer circulation time than free DOX. The in vivo imaging and biodistribution studies revealed that cRGD-HN-DOX could actively target human U87MG glioma xenograft in nude mice. The therapeutic studies in human U87MG glioma xenografts exhibited that cRGD-HN-DOX in combination with NIR irradiation completely inhibited tumor growth and possessed much lower side effects than free DOX. The Kaplan-Meier survival curves showed that all mice treated with cRGD-HN-DOX plus NIR irradiation survived over an experimental period of 48 days while control groups treated with PBS, cRGD-HN-DOX, cRGD-HNs with NIR irradiation, free DOX, or HN-DOX with NIR irradiation (non-targeting control) had short life spans of 15-40 days. Ligand-directed AuNR/PEG-PCL hybrid nanoparticles with evident tumor-targetability as well as superior spatiotemporal and rate control over drug release have emerged as an appealing platform for cancer chemotherapy in vivo.

[1]  C. Jérôme,et al.  Gold nanorods with phase-changing polymer corona for remotely near-infrared-triggered drug release. , 2014, Chemistry, an Asian journal.

[2]  Xiaoli Wei,et al.  Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Shudong Lin,et al.  Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release. , 2011, Angewandte Chemie.

[4]  Tae-You Kim,et al.  Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.

[5]  C. M. Roth,et al.  PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. , 2009, Bioconjugate chemistry.

[6]  Zhiyuan Zhong,et al.  Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. , 2011, Biomacromolecules.

[7]  Ying Sun,et al.  cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer. , 2012, Biomaterials.

[8]  F. Meng,et al.  Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Hao Yan,et al.  Toward reliable gold nanoparticle patterning on self-assembled DNA nanoscaffold. , 2008, Journal of the American Chemical Society.

[10]  Kit S Lam,et al.  Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. , 2011, Biomaterials.

[11]  Kinam Park,et al.  Blood-stable, tumor-adaptable disulfide bonded mPEG-(Cys)4-PDLLA micelles for chemotherapy. , 2013, Biomaterials.

[12]  Kai Yang,et al.  Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. , 2012, Biomaterials.

[13]  Kosuke Shimizu,et al.  RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[14]  Ru Cheng,et al.  Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. , 2009, Angewandte Chemie.

[15]  Yanjiao Jiang,et al.  Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects , 2012 .

[16]  Chaoliang He,et al.  Disulfide Cross‐Linked Polyurethane Micelles as a Reduction‐Triggered Drug Delivery System for Cancer Therapy , 2014, Advanced healthcare materials.

[17]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[18]  Cao Xie,et al.  Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[19]  Joseph Park,et al.  Specific Near‐IR Absorption Imaging of Glioblastomas Using Integrin‐Targeting Gold Nanorods , 2011 .

[20]  Ru Cheng,et al.  pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances. , 2014, Nanomedicine.

[21]  S. Regen,et al.  Permeability characteristics of lipid bilayers from lipoic acid-derived phosphatidylcholines. Comparison of monomeric, crosslinked and noncrosslinked polymerized membranes , 1988 .

[22]  Yan Xu,et al.  Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin. , 2009, Macromolecular bioscience.

[23]  Catherine J Murphy,et al.  Seeded high yield synthesis of short Au nanorods in aqueous solution. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[24]  Rui Peng,et al.  Lipoic acid modified low molecular weight polyethylenimine mediates nontoxic and highly potent in vitro gene transfection. , 2011, Molecular pharmaceutics.

[25]  Sung Eun Kim,et al.  Disulfide-cross-linked PEG-poly(amino acid)s copolymer micelles for glutathione-mediated intracellular drug delivery. , 2008, Chemical communications.

[26]  Y. Bae,et al.  Stability issues of polymeric micelles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Patrick Couvreur,et al.  Design, Functionalization Strategies and Biomedical Applications of Targeted Biodegradable/Biocompatible Polymer‐Based Nanocarriers for Drug Delivery , 2013 .

[28]  Yi Yan Yang,et al.  Self-assembled polymer nanostructures for delivery of anticancer therapeutics , 2009 .

[29]  M. Vos,et al.  Self-assembled hybrid oligo(p-phenylenevinylene)-gold nanoparticle tapes. , 2007, Angewandte Chemie.

[30]  Karen L Wooley,et al.  Design of polymeric nanoparticles for biomedical delivery applications. , 2012, Chemical Society reviews.

[31]  A. Haes,et al.  Salt-mediated self-assembly of thioctic acid on gold nanoparticles. , 2011, ACS nano.

[32]  Zhuang Liu,et al.  Gold nanorod-cored biodegradable micelles as a robust and remotely controllable doxorubicin release system for potent inhibition of drug-sensitive and -resistant cancer cells. , 2013, Biomacromolecules.

[33]  Theresa M. Allen,et al.  Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors , 2005, Clinical Cancer Research.

[34]  Yinan Zhong,et al.  Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy. , 2014, Biomacromolecules.

[35]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[36]  Takahiro Nomoto,et al.  Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. , 2013, ACS nano.

[37]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[38]  Hongwei Liao and,et al.  Gold Nanorod Bioconjugates , 2005 .

[39]  U. Singh,et al.  Alpha-lipoic acid supplementation and diabetes. , 2008, Nutrition reviews.

[40]  Ru Cheng,et al.  Intracellular drug release nanosystems , 2012 .

[41]  K. Ulbrich,et al.  Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. , 2010, Biomaterials.

[42]  F. Kiessling,et al.  Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[43]  R. Martins,et al.  Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. , 2008, Advanced drug delivery reviews.

[44]  Ick Chan Kwon,et al.  Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. , 2012, Biomaterials.

[45]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[46]  S. Jeong,et al.  Ketal cross-linked poly(ethylene glycol)-poly(amino acid)s copolymer micelles for efficient intracellular delivery of doxorubicin. , 2011, Biomacromolecules.

[47]  Zhiyuan Zhong,et al.  Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. , 2013, Biomaterials.

[48]  R. Müller,et al.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.

[49]  Zhiyuan Zhong,et al.  Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release. , 2012, Biomacromolecules.

[50]  C. Hawker,et al.  Cross‐Linked Block Copolymer Micelles: Functional Nanostructures of Great Potential and Versatility , 2007 .

[51]  Atsushi Harada,et al.  Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. , 2003, Angewandte Chemie.